ES514053A0 - "procedimiento de preparacion de nuevos derivados de la quinoleina". - Google Patents
"procedimiento de preparacion de nuevos derivados de la quinoleina".Info
- Publication number
- ES514053A0 ES514053A0 ES514053A ES514053A ES514053A0 ES 514053 A0 ES514053 A0 ES 514053A0 ES 514053 A ES514053 A ES 514053A ES 514053 A ES514053 A ES 514053A ES 514053 A0 ES514053 A0 ES 514053A0
- Authority
- ES
- Spain
- Prior art keywords
- carbon atoms
- group
- alkyl
- hydrogen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XNMYNYSCEJBRPZ-UHFFFAOYSA-N 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine Chemical class C1=CC=C2C(OCCN(C)C)=NC(CCCC)=CC2=C1 XNMYNYSCEJBRPZ-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 208000027534 Emotional disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003236 psychic effect Effects 0.000 abstract 1
- BLTDCIWCFCUQCB-UHFFFAOYSA-N quinoline-3-carboxamide Chemical class C1=CC=CC2=CC(C(=O)N)=CN=C21 BLTDCIWCFCUQCB-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002653 sulfanylmethyl group Chemical group [H]SC([H])([H])[*] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8113957A FR2509728A1 (fr) | 1981-07-17 | 1981-07-17 | Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8305335A1 ES8305335A1 (es) | 1983-04-01 |
| ES514053A0 true ES514053A0 (es) | 1983-04-01 |
Family
ID=9260604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES514053A Granted ES514053A0 (es) | 1981-07-17 | 1982-07-16 | "procedimiento de preparacion de nuevos derivados de la quinoleina". |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4450167A (enExample) |
| EP (1) | EP0070767B1 (enExample) |
| JP (1) | JPS5818361A (enExample) |
| KR (1) | KR880002232B1 (enExample) |
| AT (1) | ATE12635T1 (enExample) |
| AU (1) | AU552147B2 (enExample) |
| CA (1) | CA1204441A (enExample) |
| DE (1) | DE3262985D1 (enExample) |
| ES (1) | ES514053A0 (enExample) |
| FI (1) | FI77654C (enExample) |
| FR (1) | FR2509728A1 (enExample) |
| HU (1) | HU186561B (enExample) |
| ZA (1) | ZA824746B (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2564832B1 (fr) * | 1984-05-23 | 1987-05-15 | Panmedica Sa | Nouveaux n-acyl derives d'amino-acides et leurs esters, leur procede de preparation et medicaments les contenant |
| ZA854556B (en) * | 1984-06-25 | 1986-08-27 | Roussel Uclaf | Derivatives of isoxazoloquinolinone,process and intermediates for preparation,use as medicaments,and compositions containing them |
| FR2566405B1 (fr) * | 1984-06-25 | 1986-09-26 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus |
| US4602014A (en) * | 1984-07-09 | 1986-07-22 | Ciba-Geigy Corporation | Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators |
| EP0172004B1 (en) * | 1984-08-15 | 1990-03-21 | The Boots Company PLC | Quinolinones, process for their preparation and pharmaceutical compositions containing them |
| FR2585356B1 (fr) * | 1985-07-25 | 1987-10-23 | Roussel Uclaf | Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant |
| FR2593810B1 (fr) * | 1986-01-24 | 1988-04-22 | Sanofi Sa | Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant |
| FR2593811B1 (fr) * | 1986-01-24 | 1989-03-31 | Sanofi Sa | Derives alcoyl-1 oxo-4 dihydro-1,4 quinoleine carboxamide-3, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant |
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| GB8610980D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Heterocyclic fused tricyclic compounds |
| US5235054A (en) * | 1992-07-15 | 1993-08-10 | Pfizer Inc. | 3-carboxaldehyde substituted quinolines and naphthyridines |
| IL127559A0 (en) * | 1996-06-20 | 1999-10-28 | Univ Texas | Compounds and methods for providing pharmacologically active preparations and uses thereof |
| DE19738616A1 (de) * | 1997-09-04 | 1999-03-11 | Clariant Gmbh | 4-Hydroxychinolin-3-carbonsäure-Derivate als Lichtschutzmittel |
| US6429207B1 (en) * | 1997-11-21 | 2002-08-06 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| AU771358B2 (en) * | 1997-11-21 | 2004-03-18 | Astrazeneca Ab | Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| EP1048655B1 (en) * | 1997-12-03 | 2004-09-01 | Taisho Pharmaceutical Co., Ltd | 1,2-dihydro-2-oxoquinoline derivatives |
| EP1042295B1 (en) * | 1997-12-22 | 2005-09-07 | Pharmacia & Upjohn Company LLC | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| AU2794099A (en) | 1998-02-26 | 1999-09-15 | Neurogen Corporation | Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands |
| MXPA01011173A (es) * | 1999-05-06 | 2002-04-24 | Neurogen Corp | 4-0x0-quinolin-3-carboxamidas sustituidas: ligandos del receptor cerebro de gaba. |
| US8354427B2 (en) * | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
| CA2881078C (en) * | 2004-06-24 | 2018-10-02 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
| WO2007075901A2 (en) * | 2005-12-24 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Quinolin- 4 - one derivatives as modulators of abc transporters |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| US12458635B2 (en) | 2008-08-13 | 2025-11-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administrations thereof |
| MX2011004375A (es) | 2008-10-23 | 2013-03-07 | Vertex Pharma | Moduladores del regulador de conductancia transmembrana de fibrosis quistica. |
| SI3330255T1 (sl) | 2009-03-20 | 2021-03-31 | Vertex Pharmaceuticals Incorporated | Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi |
| MX2013000748A (es) | 2010-08-27 | 2013-03-05 | Gruenenthal Gmbh | 2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
| KR20130100300A (ko) | 2010-08-27 | 2013-09-10 | 그뤼넨탈 게엠베하 | Ｋｃｎｑ２／３ 조절제로서의 치환된 ２-옥시-퀴놀린-３-카복스아미드 |
| CA2804824A1 (en) * | 2010-08-27 | 2012-03-01 | Gruenenthal Gmbh | Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
| PL2609086T3 (pl) | 2010-08-27 | 2015-07-31 | Gruenenthal Gmbh | Podstawione 2-okso- i 2-tiookso-dihydrochinolino-3-karboksyamidy jako modulatory KCNQ2/3 |
| BR112013005056A2 (pt) | 2010-09-01 | 2016-05-31 | Gruenenthal Gmbh | 1-oxo-di-hidroisoquinolina-3-carboxamidas substituídas como moduladores kcnq2/3 |
| US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| EP2819670B1 (en) | 2012-02-27 | 2026-05-20 | Vertex Pharmaceuticals Incorporated | Pharmaceutical Composition and Their Administration |
| CA2963945C (en) | 2014-10-07 | 2023-01-10 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
| EP3664822A4 (en) * | 2017-08-04 | 2021-07-07 | Axial Therapeutics, Inc. | MICROBIAL INDUCED AMYLOID FORMATION INHIBITORS |
| GB202016245D0 (en) * | 2020-10-13 | 2020-11-25 | Univ College Cardiff Consultants Ltd | Compounds |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR960299A (enExample) * | 1950-04-15 | |||
| DE540697C (de) * | 1925-08-11 | 1933-01-28 | Chemische Ind Ges | Verfahren zur Darstellung einseitig acylierter Diamine |
| US2504875A (en) * | 1945-06-04 | 1950-04-18 | Us Sec War | Method for producing 4-hydroxyquinolines |
| US2504896A (en) * | 1945-06-04 | 1950-04-18 | Us Sec War | Method of preparing intermediates suitable for conversion into nuclear substituted heterocyclic compounds |
| US2614121A (en) * | 1946-03-01 | 1952-10-14 | Charles C Price | Process for making intermediates for producing basic compounds |
| US2798070A (en) * | 1954-02-04 | 1957-07-02 | Mcneilab Inc | Quaternary quinoline carboxamide salts and method of preparing same |
| DE1908548A1 (de) * | 1968-02-29 | 1970-11-05 | Warner Lambert Co | Chinolinderivate |
| US3755332A (en) * | 1971-07-01 | 1973-08-28 | Ciba Geigy Corp | Substituted 4 indazolaminoquinolines |
| GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
| FR2221126B2 (enExample) * | 1973-03-12 | 1977-01-28 | Roussel Uclaf | |
| CA1034124A (en) * | 1973-05-11 | 1978-07-04 | Ciba-Geigy Ag | Process for the manufacture of new quinolines |
| CH578536A5 (en) * | 1973-05-11 | 1976-08-13 | Ciba Geigy Ag | Quinoline-3-carboxylic acid derivs - with e.g. analgesic, antinociceptive, antiinflammatory and antiallergic props |
| FR2281761A1 (fr) * | 1974-08-13 | 1976-03-12 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
| JPS5291876A (en) * | 1976-01-27 | 1977-08-02 | Roussel Uclaf | Novel derivatives of 33quinolinecarboxylic acid and medicine comprising same |
| FR2340735A1 (fr) * | 1976-02-11 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
| DE2730061A1 (de) * | 1977-07-02 | 1979-01-18 | Bayer Ag | Verfahren zur herstellung von chinolin-derivaten |
| FR2443467A1 (fr) * | 1978-12-08 | 1980-07-04 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
| DE2854190C2 (de) * | 1978-12-15 | 1980-11-27 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von lasierenden Pigmentformen des Indanthrens und des chlorierten Indanthrone |
-
1981
- 1981-07-17 FR FR8113957A patent/FR2509728A1/fr active Granted
-
1982
- 1982-07-02 ZA ZA824746A patent/ZA824746B/xx unknown
- 1982-07-12 DE DE8282401317T patent/DE3262985D1/de not_active Expired
- 1982-07-12 AT AT82401317T patent/ATE12635T1/de not_active IP Right Cessation
- 1982-07-12 EP EP82401317A patent/EP0070767B1/fr not_active Expired
- 1982-07-14 FI FI822509A patent/FI77654C/fi not_active IP Right Cessation
- 1982-07-14 KR KR8203141A patent/KR880002232B1/ko not_active Expired
- 1982-07-15 JP JP57122246A patent/JPS5818361A/ja active Pending
- 1982-07-15 US US06/398,575 patent/US4450167A/en not_active Expired - Fee Related
- 1982-07-16 HU HU822323A patent/HU186561B/hu unknown
- 1982-07-16 ES ES514053A patent/ES514053A0/es active Granted
- 1982-07-16 CA CA000407411A patent/CA1204441A/fr not_active Expired
- 1982-07-16 AU AU86118/82A patent/AU552147B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA1204441A (fr) | 1986-05-13 |
| EP0070767A1 (fr) | 1983-01-26 |
| HU186561B (en) | 1985-08-28 |
| ES8305335A1 (es) | 1983-04-01 |
| AU552147B2 (en) | 1986-05-22 |
| FI77654C (fi) | 1989-04-10 |
| FR2509728B1 (enExample) | 1985-03-01 |
| ZA824746B (en) | 1983-04-27 |
| ATE12635T1 (de) | 1985-04-15 |
| FI822509L (fi) | 1983-01-18 |
| EP0070767B1 (fr) | 1985-04-10 |
| DE3262985D1 (en) | 1985-05-15 |
| KR840000501A (ko) | 1984-02-22 |
| AU8611882A (en) | 1983-01-20 |
| FI822509A0 (fi) | 1982-07-14 |
| KR880002232B1 (ko) | 1988-10-20 |
| FI77654B (fi) | 1988-12-30 |
| FR2509728A1 (fr) | 1983-01-21 |
| JPS5818361A (ja) | 1983-02-02 |
| US4450167A (en) | 1984-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU552147B2 (en) | Quinoline derivatives | |
| ES517699A0 (es) | Procedimiento de preparacion de nuevas pirimido-quinoxalinas. | |
| ES550003A0 (es) | Procedimiento para preparar imidazo (1,2-c)pirimidinas | |
| ES510483A0 (es) | "un procedimiento para preparar derivados de imidazo(1,2-a)quinoleina". | |
| FI803654L (fi) | Nya substituerade 2-fenylaminoimidazoliner-(2) deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande | |
| AU551901B2 (en) | Substituted thienobenzodiazepinones | |
| FI851308A0 (fi) | Foerfarande foer framstaellning av nya 1,2,4-tiadiaziner. | |
| ZA8312B (en) | Substituted 1-benzoyl-2-phenyliminiomidazolidine derivatives | |
| IL72681A0 (en) | 4-alkylimidazole derivatives,their preparation and their use as nitrification inhibitors | |
| GB2192000B (en) | Tetrahydroquinoline compounds | |
| ES535569A0 (es) | Procedimiento para preparar 11-piperazinil-5h-imidazo(2, 1-c) (1, 4) benzodiazepinas | |
| ES8307798A1 (es) | Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol. | |
| ES500108A0 (es) | Procedimiento para preparar nuevas benzotiopirano (2,3-c)pi-ridinas | |
| SE8105297L (sv) | Imidazolderivat | |
| ES457996A1 (es) | Un procedimiento para la preparacion de nuevos derivados de morfolina. | |
| ES483138A1 (es) | Un procedimiento para la preparacion de derivados de tieno- tiacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |
Effective date: 19960401 |